​

Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Arcutis Biotherapeutics Ownership Summary

Arcutis Biotherapeutics is owned by 99.59% institutional investors, 1.93% insiders. Suvretta capital management is the largest institutional shareholder, holding 9.08% of ARQT shares. Polar Capital Biotech S Inc is the top mutual fund, with 4.17% of its assets in Arcutis Biotherapeutics shares.

ARQT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArcutis Biotherapeutics99.59%1.93%-1.52%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Suvretta capital management11.54M9.08%$161.73M
Rubric capital management lp10.97M8.82%$152.77M
Jennison associates11.11M8.75%$155.75M
Frazier life sciences management9.87M7.78%$138.44M
Blackrock8.62M7.76%$80.19M
Blackrock funding, inc. /de8.53M6.72%$119.63M
Vanguard group6.44M5.18%$89.72M
State street4.95M3.98%$68.96M
Polar capital5.01M3.94%$70.19M
Gilder gagnon howe4.16M3.27%$58.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor2.12M18.43%$29.73M
Tejara capital873.38K5.68%$12.24M
Frazier life sciences management9.87M5.54%$138.44M
Suvretta capital management11.54M4.88%$161.73M
Lion point capital, lp46.30K3.38%$644.96K
Rubric capital management lp10.97M1.96%$152.77M
Pfm health sciences, lp923.38K1.11%$12.95M
Cormorant asset management, lp1.00M1.04%$14.02M
Privium fund management b.v.325.71K1.03%$4.54M
Stempoint capital lp205.67K0.93%$2.88M

Top Buyers

HolderShares% AssetsChange
Ubs group2.79M0.01%2.57M
Blackrock8.62M0.00%1.96M
Millennium management2.31M0.02%1.16M
Frazier life sciences management9.87M5.54%1.09M
Pfm health sciences, lp923.38K1.11%923.38K

Top Sellers

HolderShares% AssetsChange
Polar capital5.01M0.37%-1.70M
Paradigm biocapital advisors lp---1.47M
Perceptive advisors---1.36M
Braidwell lp---1.30M
Bain capital life sciences investors---1.03M

New Positions

HolderShares% AssetsChangeValue
Pfm health sciences, lp923.38K1.11%923.38K$12.95M
Norges bank532.79K0.00%532.79K$7.42M
Jupiter asset management412.74K0.05%412.74K$5.79M
Privium fund management b.v.325.71K1.03%325.71K$4.54M
Avidity partners management lp268.00K0.75%268.00K$3.76M

Sold Out

HolderChange
True wealth design-9.00
Parallel advisors-14.00
Nelson, van denburg & campbell wealth management group-22.00
Stephens consulting-25.00
Corecap advisors-38.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025234-6.02%126,474,0751.16%991.01%120-6.25%66-20.48%
Mar 31, 202524613.36%124,963,282-3.01%990.92%12716.51%8122.73%
Dec 31, 20242149.74%120,033,596-6.58%960.90%1073.88%6629.41%
Sep 30, 20241941.57%128,485,4751.57%1030.98%104-3.70%51-7.27%
Jun 30, 202419113.02%126,499,0251.37%1020.81%108-0.92%5544.74%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Polar Capital Biotech S Inc5.00M4.17%-
Vanguard US Total Market Shares ETF3.59M3.03%492.10K
Vanguard Total Stock Mkt Idx Inv3.39M2.83%-71.75K
Jennison SMid Cap Core Equity3.17M2.66%83.01K
PGIM Jennison Small Company A3.17M2.64%9.07K
iShares Russell 2000 ETF2.52M2.10%-47.98K
Jennison Health Sciences Equity2.27M1.90%-
PGIM Jennison Health Sciences Z2.27M1.89%-
SPDR® S&P Biotech ETF1.87M1.57%46.20K
Franklin Biotechnology Discv A(acc)USD1.69M1.41%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 08, 2025Watanabe Todd See RemarksSell$168.80K
Sep 09, 2025Watanabe Todd See RemarksSell$8.83K
Sep 04, 2025Matsuda Masaru See RemarksSell$583.72K
Sep 02, 2025Welgus Howard G.-Sell$156.38K
Aug 19, 2025Burnett Patrick See RemarksSell$28.28K

Insider Transactions Trends

DateBuySell
2025 Q3-15
2025 Q2910
2025 Q1-18
2024 Q4314
2024 Q3-9

ARQT Ownership FAQ

Who Owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics shareholders are primarily institutional investors at 99.59%, followed by 1.93% insiders and -1.52% retail investors. The average institutional ownership in Arcutis Biotherapeutics's industry, Biotech Stocks , is 306.59%, which Arcutis Biotherapeutics falls below.

Who owns the most shares of Arcutis Biotherapeutics?

Arcutis Biotherapeutics’s largest shareholders are Suvretta capital management (11.54M shares, 9.08%), Rubric capital management lp (10.97M shares, 8.82%), and Jennison associates (11.11M shares, 8.75%). Together, they hold 26.65% of Arcutis Biotherapeutics’s total shares outstanding.

Does Blackrock own Arcutis Biotherapeutics?

Yes, BlackRock owns 7.76% of Arcutis Biotherapeutics, totaling 8.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 80.19M$. In the last quarter, BlackRock increased its holdings by 1.96M shares, a 29.49% change.

Who is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Arcutis Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 18.43% of its assets in 2.12M Arcutis Biotherapeutics shares, valued at 29.73M$.

Who is the top mutual fund holder of Arcutis Biotherapeutics shares?

Polar Capital Biotech S Inc is the top mutual fund holder of Arcutis Biotherapeutics shares, with 4.17% of its total shares outstanding invested in 5M Arcutis Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools